These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10566648)

  • 1. Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy.
    Deladoëy J; Flück C; Bex M; Yoshimura N; Harada N; Mullis PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4050-4. PubMed ID: 10566648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene.
    Belgorosky A; Pepe C; Marino R; Guercio G; Saraco N; Vaiani E; Rivarola MA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5127-31. PubMed ID: 14602738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.
    Rochira V; Zirilli L; Genazzani AD; Balestrieri A; Aranda C; Fabre B; Antunez P; Diazzi C; Carani C; Maffei L
    Eur J Endocrinol; 2006 Oct; 155(4):513-22. PubMed ID: 16990650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.
    Mullis PE; Yoshimura N; Kuhlmann B; Lippuner K; Jaeger P; Harada H
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1739-45. PubMed ID: 9177373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
    Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies.
    Bouchoucha N; Samara-Boustani D; Pandey AV; Bony-Trifunovic H; Hofer G; Aigrain Y; Polak M; Flück CE
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):8-17. PubMed ID: 24705274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.
    Morishima A; Grumbach MM; Simpson ER; Fisher C; Qin K
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3689-98. PubMed ID: 8530621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome.
    Maffei L; Rochira V; Zirilli L; Antunez P; Aranda C; Fabre B; Simone ML; Pignatti E; Simpson ER; Houssami S; Clyne CD; Carani C
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):218-24. PubMed ID: 17547681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma.
    Agarwal VR; Takayama K; Van Wyk JJ; Sasano H; Simpson ER; Bulun SE
    J Clin Endocrinol Metab; 1998 May; 83(5):1797-800. PubMed ID: 9589695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement.
    Burckhardt MA; Obmann V; Wolf R; Janner M; Flück CE; Mullis PE
    Gynecol Endocrinol; 2015 May; 31(5):349-54. PubMed ID: 25585547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of serum immunoreactive luteinizing hormone and bioactive follicle-stimulating hormone by testosterone in early pubertal boys.
    Hassing JM; Padmanabhan V; Kelch RP; Brown MB; Olton PR; Sonstein JS; Foster CM; Beitins IZ
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1082-9. PubMed ID: 2108181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged pulsatile administration of luteinizing hormone-releasing hormone in prepubertal children: diagnostic and physiologic aspects.
    Delemarre-van de Waal HA; Van den Brande JL; Schoemaker J
    J Clin Endocrinol Metab; 1985 Nov; 61(5):859-67. PubMed ID: 3930552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels.
    Andersson AM; Juul A; Petersen JH; Müller J; Groome NP; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3976-81. PubMed ID: 9398699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatization mediates testosterone's short-term feedback restraint of 24-hour endogenously driven and acute exogenous gonadotropin-releasing hormone-stimulated luteinizing hormone and follicle-stimulating hormone secretion in young men.
    Schnorr JA; Bray MJ; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2600-6. PubMed ID: 11397860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of castration and chronic steroid treatments on hypothalamic gonadotropin-releasing hormone content and pituitary gonadotropins in male wild-type and estrogen receptor-alpha knockout mice.
    Lindzey J; Wetsel WC; Couse JF; Stoker T; Cooper R; Korach KS
    Endocrinology; 1998 Oct; 139(10):4092-101. PubMed ID: 9751487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of P450 aromatase enhances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E.
    Wickman S; Dunkel L
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4887-94. PubMed ID: 11600558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW; Gordon K; Billiar RB; Little AB
    Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gonadotropin, sex steroid, and immunoreactive inhibin levels in the first two years of life.
    Burger HG; Yamada Y; Bangah ML; McCloud PI; Warne GL
    J Clin Endocrinol Metab; 1991 Mar; 72(3):682-6. PubMed ID: 1900069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.